Nutriband Inc (NTRB)
Healthcare
Biotechnology
2.90 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Nutriband Inc (NTRB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 43.4% of the shares are freely tradable; institutional investors hold 3.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
3.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
71.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
43.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
12Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 1.67 | 202,738 | +0.0 | 12/31/2025 |
| Vanguard Capital Management, LLC | 1.44 | 174,927 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.58 | 70,053 | +16.9 | 03/31/2026 |
| UBS Group AG | 0.27 | 32,664 | +2,515.2 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.21 | 25,111 | +0.0 | 03/31/2026 |
| State Street Corp | 0.21 | 24,966 | +0.0 | 03/31/2026 |
| Northern Trust Corp | 0.11 | 13,945 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.01 | 122,586 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.43 | 52,341 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.28 | 33,871 | -0.4 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.